Страна: Австралія
мова: англійська
Джерело: Department of Health (Therapeutic Goods Administration)
Dicloxacillin sodium
Bristol-Myers Squibb Australia Pty Ltd
Medicine Registered
Diclocil Capsules V3.0 PRODUCT INFORMATION DICLOCIL ® (DICLOXACILLIN SODIUM) CAPSULES NAME OF THE DRUG Dicloxacillin sodium is sodium (6R)-6-[3-(2,6-dichlorophenyl)-5-methylisoxazole-4- carboxamido]-penicillanate monohydrate; it is a penicillinase-resistant, acid-resistant, semisynthetic penicillin with the following structure. DESCRIPTION Dicloxacillin sodium is a white or off-white crystalline powder. Diclocil capsules contain dicloxacillin sodium equivalent to 500mg dicloxacillin. Inactive ingredients are magnesium stearate, silica colloidal anhydrous, gelatin and titanium dioxide. PHARMACOLOGY _Pharmacokinetics:_ Dicloxacillin is resistant to destruction by acid. Absorption from the gastrointestinal tract is rapid, in fasting adults, 50% to 94% of an oral dose was absorbed with peak serum levels reached within 0.5 to 2 hours. Food in the gastrointestinal tract decreases the absorption of dicloxacillin. Serum levels after oral administration are directly proportional to dosage at unit doses of 125mg, 250mg, and 500mg as measured at the 2-hour level. Single oral doses of dicloxacillin 500 mg produced peak serum concentrations of 10 to 18 _µ_g/mL. Dicloxacillin is 95% to 99% bound to serum proteins, mainly albumin. Dicloxacillin is distributed into bone, bile, pleural fluid, and synovial fluid. Only minimal concentrations are attained in cerebrospinal fluid. The elimination half-life of dicloxacillin is approximately 0.7 hours. Dicloxacillin is partially metabolized to microbiologically active (5-hydroxymethyl derivative of dicloxacillin) and Diclocil Capsules V3.0 2 inactive metabolites. Dicloxacillin and its metabolites are rapidly excreted in the ur Прочитайте повний документ